Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study

Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study

Abstract Background Little is known about whether tolerability and adherence to treatment can be influenced by weather and temperature conditions. The objective of this study was to assess monthly and seasonal adherence to and safety of sc IFN-β1a (Rebif®, Merck) in relapsing-remitting multiple scle...

Full description

Bibliographic Details
Main Authors: Spyros N. Deftereos, Evangelos Koutlas, Efrosini Koutsouraki, Athanassios Kyritsis, Panagiotis Papathanassopoulos, Nikolaos Fakas, Vaia Tsimourtou, Nikolaos Vlaikidis, Antonios Tavernarakis, Konstantinos Voumvourakis, Michalis Arvanitis, Dimitrios Sakellariou, Filippo DeLorenzo
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Interferons
Rebif
Rebismart
Treatment adherence and compliance
Clinical efficacy
Online Access:http://link.springer.com/article/10.1186/s12883-018-1179-0

Internet

http://link.springer.com/article/10.1186/s12883-018-1179-0

Similar Items